Gene · 2822
Papers4,132
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,132
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Loxosceles amazonica Brown Spider venom: Insights into enzymatic activities, immunorecognition, and novel phospholipase D isoforms. | Biochimie | 2024 | 38944106 | PubTator, text mining | PubMed |
| Mechanistic Characterization of De Novo Generation of Variable Number Tandem Repeats in Circular Plasmids during Site-Directed Mutagenesis and Optimization for Coding Gene Application. | Adv Biol (Weinh) | 2024 | 38880850 | PubTator, text mining | PubMed |
| Fraternal twins at work: Structures of PLD3/4 reveal mechanism for lysosomal nucleic acid breakdown. | Structure | 2024 | 38848679 | PubTator, text mining | PubMed |
| Exercise activates interferon response of the liver via Gpld1 to enhance antiviral innate immunity. | Sci Adv | 2024 | 38809975 | PubTator, text mining | PubMed |
| Decreased Expression of PLD2 Promotes EMT in Colorectal Cancer Invasion and Metastasis. | J Cancer | 2024 | 38706911 | PubTator, text mining | PubMed |
| PLD2 deficiency alleviates endothelial glycocalyx degradation in LPS-induced ARDS/ALI. | Biochem Biophys Res Commun | 2024 | 38703555 | PubTator, text mining | PubMed |
| Lysosomal endonuclease RNase T2 and PLD exonucleases cooperatively generate RNA ligands for TLR7 activation. | Immunity | 2024 | 38697119 | PubTator, text mining | PubMed |
| Characterization of winged helix domain fusion endonucleases as N6-methyladenine-dependent type IV restriction systems. | Front Microbiol | 2024 | 38655080 | PubTator, text mining | PubMed |
| Oleate Promotes Triple-Negative Breast Cancer Cell Migration by Enhancing Filopodia Formation through a PLD/Cdc42-Dependent Pathway. | Int J Mol Sci | 2024 | 38612766 | PubTator, text mining | PubMed |
| "Blue Light, Camera, Action!" | ACS Cent Sci | 2024 | 38559309 | PubTator, text mining | PubMed |
| Ultralow Background Membrane Editors for Spatiotemporal Control of Phosphatidic Acid Metabolism and Signaling. | ACS Cent Sci | 2024 | 38559292 | PubTator, text mining | PubMed |
| Brain mechanisms involved in the perception of emotional gait: A combined magnetoencephalography and virtual reality study. | PLoS One | 2024 | 38551903 | PubTator, text mining | PubMed |
| Structural and mechanistic insights into disease-associated endolysosomal exonucleases PLD3 and PLD4. | Structure | 2024 | 38537643 | PubTator, text mining | PubMed |
| Characterization of Lysophospholipase D Activity in Mammalian Cell Membranes. | Cells | 2024 | 38534364 | PubTator, text mining | PubMed |
| Proteomic characteristics of the treatment trajectory of patients with COVID-19. | Arch Virol | 2024 | 38532129 | PubTator, text mining | PubMed |
| Reproducibility of arterial spin labeling cerebral blood flow image processing: A report of the ISMRM open science initiative for perfusion imaging (OSIPI) and the ASL MRI challenge. | Magn Reson Med | 2024 | 38502108 | PubTator, text mining | PubMed |
| Phospholipase D, a Novel Therapeutic Target Contributes to the Pathogenesis of Neurodegenerative and Neuroimmune Diseases. | Anal Cell Pathol (Amst) | 2024 | 38487684 | PubTator, text mining | PubMed |
| Platycodon D protects human nasal epithelial cells from pyroptosis through the Nrf2/HO-1/ROS signaling cascade in chronic rhinosinusitis. | Chin Med | 2024 | 38433216 | PubTator, text mining | PubMed |
| Differences between Acute Embolic and Atherosclerotic Middle Cerebral Artery Occlusion in Multiphase Arterial Spin-labeling Imaging. | Neurol Med Chir (Tokyo) | 2024 | 38432944 | PubTator, text mining | PubMed |
| Role of phosphatidic acid lipids on plasma membrane association of the Ebola virus matrix protein VP40. | Biochim Biophys Acta Mol Cell Biol Lipids | 2024 | 38360201 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2822/papers?page=10